Capital Impact Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $594K | Sell |
|
|||||
|
2024
Q1 | $880K | Buy |
|
|||||
|
2023
Q4 | $797K | Buy |
|
|||||
|
2023
Q3 | $360K | Hold |
|
|||||
|
2023
Q2 | $464K | Buy |
|
|||||
|
2023
Q1 | $399K | Hold |
|
|||||
|
2022
Q4 | $373K | Sell |
|
|||||
|
2022
Q3 | $586K | Buy |
|
|||||
|
2022
Q2 | $595K | Buy |
|
|||||
|
2022
Q1 | $596K | Buy |
|
|||||
|
2021
Q4 | $575K | Sell |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $359K | Sell |
|
|||||
|
2020
Q4 | $12M | Buy |
|
|||||
|
2020
Q3 | $2.19M | Buy |
|